FDA Inspection
Central Jersey Blood Center, Inc.Central Jersey Blood Center, Inc. – FDA Inspection, Jul 10, 2009
Record Details
This FDA Inspection record concerns Central Jersey Blood Center, Inc., with an inspection on July 10, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 10, 2009
- Product Type
- Biologics
View Company Profile
ID · b9da04df-07d3-4852-b75f-8f6a9824cd7b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 604248
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.40(a)(1)Provide space for examination
- 21 CFR 606.40Suitable size, construction, etc.
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Central Jersey Blood Center, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 2, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 4, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 12, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 16, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Central Jersey Blood Center, Inc.
- FDA Inspection 1003831 - 2017-03-02
- FDA Inspection 904963 - 2014-11-04
- FDA Inspection 822454 - 2013-03-12
- FDA Inspection 733293 - 2011-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.